Haydee Verduzco-Aguirre, MD

Articles by Haydee Verduzco-Aguirre, MD

69-Year-Old Man With Castration-Resistant Prostate Cancer Progressing After Docetaxel and Androgen Receptor-Targeting Agent

ByEduardo Gonzalez-Ochoa, MD,Haydee Verduzco-Aguirre, MD,E. David Crawford, MD,María T. Bourlon, MD, MSc, FASCO

April 10th 2020

Experts discuss the case of a 69-year-old man with a history of metastatic prostate cancer previously treated with androgen deprivation therapy with leuprolide.

Latest Updated Articles

69-Year-Old Man With Castration-Resistant Prostate Cancer Progressing After Docetaxel and Androgen Receptor-Targeting Agent
April 10th 2020

Haydee Verduzco-Aguirre, MD

Articles by Haydee Verduzco-Aguirre, MD

69-Year-Old Man With Castration-Resistant Prostate Cancer Progressing After Docetaxel and Androgen Receptor-Targeting Agent

Latest Updated Articles

Trending on CancerNetwork

FDA Approves Zenocutuzumab in NRG1+ Cholangiocarcinoma Post Systemic Therapy

Daraxonrasib Shows Anti-Tumor Activity in Pretreated RAS+ Pancreatic Cancer

FDA Clears AI Stratification Tool in HR+/HER2– Invasive Breast Cancer

FDA Accepts sNDA for Taletrectinib in ROS1-Positive NSCLC

Achieving a “Functional Cure” With Multiple Myeloma Therapy